Title : Pharmacokinetics in stable heart transplant recipients after conversion from twice-daily to once-daily tacrolimus formulations.

Pub. Date : 2011 Sep

PMID : 21493098






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 CONCLUSIONS: This study provides evidence for successful conversion from tacrolimus BID to QD on a 1:1 (mg/mg) total daily dose basis. Tacrolimus BH3 interacting domain death agonist Homo sapiens
2 Adverse events were reported by approximately one-tenth of patients receiving tacrolimus BID and a quarter of those who received QD. Tacrolimus BH3 interacting domain death agonist Homo sapiens